Atlas Trials

Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib

Clinical trial NCT06083038 · COMPLETED

Trial details

NCT number
NCT06083038
Sponsor
HealthPartners Institute
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Breast Cancer
Start date
2023-10-05
Primary completion
2025-01-13
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.